{"id":"https://openalex.org/W7204235249","doi":"https://doi.org/10.1038/s41598-026-66508-y","title":"A THBS2+ cancer-associated fibroblast subpopulation orchestrates therapeutic resistance in castration-resistant prostate cancer","display_name":"A THBS2+ cancer-associated fibroblast subpopulation orchestrates therapeutic resistance in castration-resistant prostate cancer","publication_year":2026,"publication_date":"2026-08-26","ids":{"openalex":"https://openalex.org/W7204235249","doi":"https://doi.org/10.1038/s41598-026-66508-y"},"language":"en","primary_location":{"id":"doi:10.1038/s41598-026-66508-y","doi":"https://doi.org/10.1038/s41598-026-66508-y","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-026-66508-y","pdf_url":null,"source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1038/s41598-026-66508-y","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081887821","display_name":"Qingbiao Chen","orcid":"https://orcid.org/0009-0006-5765-8841","observed_orcids":["https://orcid.org/0009-0006-5765-8841"]},"institutions":[{"id":"https://openalex.org/I190242452","display_name":"Guangdong Pharmaceutical University","ror":"https://ror.org/02vg7mz57","country_code":"CN","type":"education","lineage":["https://openalex.org/I190242452"]},{"id":"https://openalex.org/I4210135043","display_name":"Foshan Second People's Hospital","ror":"https://ror.org/03h7jyq46","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210135043"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Qingbiao Chen","raw_affiliation_strings":["Department of Urology, the Second People\u2019 s Hospital of Foshan, Affiliated Foshan Hospital of Guangdong Pharmaceutical University, Foshan, 528000, Guangdong Province, China"],"raw_orcid":"https://orcid.org/0009-0006-5765-8841","affiliations":[{"raw_affiliation_string":"Department of Urology, the Second People\u2019 s Hospital of Foshan, Affiliated Foshan Hospital of Guangdong Pharmaceutical University, Foshan, 528000, Guangdong Province, China","institution_ids":["https://openalex.org/I190242452","https://openalex.org/I4210135043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026216260","display_name":"Zexi He","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I190242452","display_name":"Guangdong Pharmaceutical University","ror":"https://ror.org/02vg7mz57","country_code":"CN","type":"education","lineage":["https://openalex.org/I190242452"]},{"id":"https://openalex.org/I4210135043","display_name":"Foshan Second People's Hospital","ror":"https://ror.org/03h7jyq46","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210135043"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zexi He","raw_affiliation_strings":["Department of Urology, the Second People\u2019 s Hospital of Foshan, Affiliated Foshan Hospital of Guangdong Pharmaceutical University, Foshan, 528000, Guangdong Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, the Second People\u2019 s Hospital of Foshan, Affiliated Foshan Hospital of Guangdong Pharmaceutical University, Foshan, 528000, Guangdong Province, China","institution_ids":["https://openalex.org/I190242452","https://openalex.org/I4210135043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148342657","display_name":"Qi Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I190242452","display_name":"Guangdong Pharmaceutical University","ror":"https://ror.org/02vg7mz57","country_code":"CN","type":"education","lineage":["https://openalex.org/I190242452"]},{"id":"https://openalex.org/I4210135043","display_name":"Foshan Second People's Hospital","ror":"https://ror.org/03h7jyq46","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210135043"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qi Wang","raw_affiliation_strings":["Department of Urology, the Second People\u2019 s Hospital of Foshan, Affiliated Foshan Hospital of Guangdong Pharmaceutical University, Foshan, 528000, Guangdong Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, the Second People\u2019 s Hospital of Foshan, Affiliated Foshan Hospital of Guangdong Pharmaceutical University, Foshan, 528000, Guangdong Province, China","institution_ids":["https://openalex.org/I190242452","https://openalex.org/I4210135043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043994717","display_name":"Jingbo Lin","orcid":"https://orcid.org/0009-0008-7898-6240","observed_orcids":["https://orcid.org/0009-0008-7898-6240"]},"institutions":[{"id":"https://openalex.org/I190242452","display_name":"Guangdong Pharmaceutical University","ror":"https://ror.org/02vg7mz57","country_code":"CN","type":"education","lineage":["https://openalex.org/I190242452"]},{"id":"https://openalex.org/I4210135043","display_name":"Foshan Second People's Hospital","ror":"https://ror.org/03h7jyq46","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210135043"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jingbo Lin","raw_affiliation_strings":["Department of Urology, the Second People\u2019 s Hospital of Foshan, Affiliated Foshan Hospital of Guangdong Pharmaceutical University, Foshan, 528000, Guangdong Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, the Second People\u2019 s Hospital of Foshan, Affiliated Foshan Hospital of Guangdong Pharmaceutical University, Foshan, 528000, Guangdong Province, China","institution_ids":["https://openalex.org/I190242452","https://openalex.org/I4210135043"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5148223827","display_name":"Qiuyong Zheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I190242452","display_name":"Guangdong Pharmaceutical University","ror":"https://ror.org/02vg7mz57","country_code":"CN","type":"education","lineage":["https://openalex.org/I190242452"]},{"id":"https://openalex.org/I4210135043","display_name":"Foshan Second People's Hospital","ror":"https://ror.org/03h7jyq46","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210135043"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Qiuyong Zheng","raw_affiliation_strings":["Department of Urology, the Second People\u2019 s Hospital of Foshan, Affiliated Foshan Hospital of Guangdong Pharmaceutical University, Foshan, 528000, Guangdong Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, the Second People\u2019 s Hospital of Foshan, Affiliated Foshan Hospital of Guangdong Pharmaceutical University, Foshan, 528000, Guangdong Province, China","institution_ids":["https://openalex.org/I190242452","https://openalex.org/I4210135043"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5081887821","https://openalex.org/A5148223827"],"corresponding_institution_ids":["https://openalex.org/I190242452","https://openalex.org/I4210135043"],"apc_list":{"value":2690,"currency":"USD","value_usd":2690},"apc_paid":{"value":2690,"currency":"USD","value_usd":2690},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.69813715,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.8880000114440918},{"id":"https://openalex.org/keywords/cancer-associated-fibroblasts","display_name":"cancer-associated fibroblasts","score":0.9670000076293945},{"id":"https://openalex.org/keywords/thbs2","display_name":"thrombospondin-2","score":0.984000027179718},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7799999713897705},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.6140000224113464},{"id":"https://openalex.org/keywords/androgen-deprivation-therapy-resistance","display_name":"androgen deprivation therapy resistance","score":0.8709999918937683},{"id":"https://openalex.org/keywords/enzalutamide","display_name":"enzalutamide","score":0.8579999804496765},{"id":"https://openalex.org/keywords/fibroblast-heterogeneity","display_name":"fibroblast heterogeneity","score":0.8169999718666077},{"id":"https://openalex.org/keywords/stromal-remodeling","display_name":"stromal remodeling","score":0.6819999814033508},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7960000038146973},{"id":"https://openalex.org/keywords/endocrine-therapy-sensitivity","display_name":"endocrine therapy sensitivity","score":0.6000000238418579}],"concepts":[{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.8083999752998352},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.8043000102043152},{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.6935999989509583},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6147000193595886},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.6057999730110168},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5655999779701233},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.5476999878883362},{"id":"https://openalex.org/C2909706936","wikidata":"https://www.wikidata.org/wiki/Q42417562","display_name":"Cancer-Associated Fibroblasts","level":4,"score":0.5141000151634216},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.46779999136924744},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.45680001378059387},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.38280001282691956},{"id":"https://openalex.org/C52124034","wikidata":"https://www.wikidata.org/wiki/Q557179","display_name":"Stroma","level":3,"score":0.3806000053882599},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.3686999976634979},{"id":"https://openalex.org/C87874733","wikidata":"https://www.wikidata.org/wiki/Q18039844","display_name":"PCA3","level":4,"score":0.3427000045776367},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31610000133514404},{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.30709999799728394},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.30649998784065247},{"id":"https://openalex.org/C2780381497","wikidata":"https://www.wikidata.org/wiki/Q463418","display_name":"Fibroblast","level":3,"score":0.29750001430511475},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.2953000068664551},{"id":"https://openalex.org/C2781188995","wikidata":"https://www.wikidata.org/wiki/Q6934982","display_name":"Multiplex","level":2,"score":0.26820001006126404},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.26579999923706055},{"id":"https://openalex.org/C193270364","wikidata":"https://www.wikidata.org/wiki/Q17141925","display_name":"Tissue microarray","level":3,"score":0.26489999890327454},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2628999948501587},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.2578999996185303},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.257099986076355},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.25690001249313354}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1038/s41598-026-66508-y","doi":"https://doi.org/10.1038/s41598-026-66508-y","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-026-66508-y","pdf_url":null,"source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1038/s41598-026-66508-y","doi":"https://doi.org/10.1038/s41598-026-66508-y","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-026-66508-y","pdf_url":null,"source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.979200005531311,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"No poverty","score":0.4529339075088501,"id":"https://metadata.un.org/sdg/1"},{"display_name":"Good health and well-being","score":0.44163158535957336,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"The":[0],"progression":[1,263],"from":[2,52],"hormone-sensitive":[3],"prostate":[4,10,114,190,211],"cancer":[5,11,115,191,212],"(HSPC)":[6],"to":[7,26,60,154,214,245,248],"lethal":[8],"castration-resistant":[9],"(CRPC)":[12],"involves":[13],"a":[14,35,72,123,224,257,265],"poorly":[15],"understood":[16],"remodeling":[17],"of":[18,45,95,126],"the":[19,29,96,146],"tumor":[20,173],"microenvironment":[21],"(TME).":[22],"This":[23,221],"study":[24,222],"aimed":[25],"comprehensively":[27],"characterize":[28],"stromal":[30,185,259],"alterations":[31],"driving":[32],"CRPC,":[33,234],"with":[34,113,118,135,169,196,236],"focus":[36],"on":[37,90],"heterogeneous":[38],"cancer-associated":[39],"fibroblast":[40],"(CAF)":[41],"subpopulations.":[42],"Integrated":[43],"analysis":[44,121],"multiple":[46],"single-cell":[47],"RNA":[48],"sequencing":[49],"(scRNA-seq)":[50],"datasets":[51],"human":[53],"HSPC":[54],"and":[55,86,109,156,176,182,193,209,239,242,264,269],"CRPC":[56,262],"samples":[57],"was":[58,151,157],"performed":[59],"map":[61],"TME":[62],"dynamics.":[63],"Fibroblast":[64],"subclustering":[65],"identified":[66,131],"distinct":[67],"CAF":[68,133,228],"subsets.":[69],"Findings":[70],"for":[71],"key":[73],"subpopulation":[74,229],"were":[75,100],"validated":[76,159],"using":[77,104],"independent":[78,161],"scRNA-seq":[79,120,162],"cohorts,":[80],"bulk":[81],"transcriptomic":[82,147],"data,":[83],"immunohistochemistry":[84],"(IHC),":[85],"multiplex":[87],"immunofluorescence":[88],"(mIF)":[89],"clinical":[91],"specimens.":[92],"Functional":[93],"roles":[94],"marker":[97],"gene":[98],"THBS2":[99,136,149,166,186,200,206,226,253],"investigated":[101],"in":[102,107,128,143,189,202,217,233,251,261],"vitro":[103],"shRNA-mediated":[105],"knockdown":[106,201],"CAFs":[108,127,138,155,203,255],"conditioned":[110,218],"media":[111,219],"assays":[112],"cells":[116,213],"treated":[117],"enzalutamide.":[119],"revealed":[122],"significant":[124],"expansion":[125],"CRPC.":[129,144],"Subclustering":[130],"five":[132],"subsets,":[134],"+":[137,227,254],"(CAF-C0)":[139],"being":[140],"specifically":[141],"enriched":[142],"At":[145],"level,":[148],"expression":[150,167],"predominantly":[152],"localized":[153],"consistently":[158],"across":[160],"datasets.":[163],"Clinically,":[164],"high":[165],"correlated":[168],"ADT":[170],"resistance,":[171],"advanced":[172],"stage,":[174],"metastasis,":[175],"shorter":[177],"biochemical":[178],"recurrence-free":[179],"survival.":[180],"IHC":[181],"mIF":[183],"confirmed":[184],"protein":[187],"upregulation":[188],"tissues":[192],"its":[194],"association":[195],"aggressive":[197],"features.":[198],"Functionally,":[199],"significantly":[204],"diminished":[205],"secretion":[207],"levels":[208],"sensitized":[210],"enzalutamide":[215],"treatment":[216],"assays.":[220],"identifies":[223],"specific":[225],"that":[230],"is":[231],"expanded":[232],"associated":[235],"therapy":[237,250],"resistance":[238],"poor":[240],"prognosis,":[241],"functionally":[243],"contributes":[244],"reduced":[246],"sensitivity":[247],"endocrine":[249],"vitro.":[252],"represent":[256],"critical":[258],"component":[260],"promising":[266],"therapeutic":[267],"target":[268],"biomarker.":[270]},"counts_by_year":[],"updated_date":"2026-09-21T07:43:02.447757","created_date":"2026-08-27T00:00:00"}